Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CareDx, Inc.CDNA · Entity 4344 | Chief Scientific Officer | January 29, 2018 | January 30, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CareDx, Inc.
Report date January 29, 2018 · Filed January 30, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 22,309 |
Reported balance
After 2018-01-29 transaction · row 1
1 source rowRow 1 · 2018-01-29 · Tax withholding · Disposed 805 · Balance 22,309 F1: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 29, 2018 Filed Jan 30, 2018 21:59 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 805 | $6.25 | $5,031.25 |
DisclosureSEC source: 0000899243-18-002272 · doc4.xml · nonDerivative · entry 1 Sninsky John Joseph · CIK 0001630732 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,309 F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain restricted stock units. Read SEC document |
| January 22, 2018 Filed Jan 23, 2018 23:49 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 886 | $6.29 | $5,572.94 |
DisclosureSEC source: 0000899243-18-001705 · doc4.xml · nonDerivative · entry 1 Sninsky John Joseph · CIK 0001630732 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,114 F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain restricted stock units. Read SEC document |
| September 01, 2017 Filed Sep 5, 2017 22:32 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $2.80 | $0.00 |
DisclosureSEC source: 0000899243-17-021475 · doc4.xml · derivative · entry 1 Sninsky John Joseph · CIK 0001630732 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-09-01 F1 · derivative.exercise_date: 50% of the shares subject to the option shall vest on September 1, 2018 and 1/72nd of the shares subject to the option shall vest monthly thereafter. Read SEC document |
| February 17, 2017 Filed Feb 22, 2017 23:38 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantEmployee Stock Option (right to buy) · Derivative | 27,000 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0000899243-17-005009 · doc4.xml · derivative · entry 2 Sninsky John Joseph · CIK 0001630732 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,000 Underlying: Common Stock · 27,000 shares Expires 2027-02-17 F3 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on January 27, 2018 and 1/48th of the shares subject to the option shall vest monthly thereafter. Read SEC document |
| February 17, 2017 Filed Feb 22, 2017 23:38 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-005009 · doc4.xml · nonDerivative · entry 1 Sninsky John Joseph · CIK 0001630732 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 F1 · shares: The reported securities are represented by restricted stock units 1/4th of which shall vest on January 27, 2018 and 1/4th of which shall vest on each yearly anniversary thereafter. F2 · balance_after: Includes 3,000 shares that Reporting Person acquired pursuant to Issuer's 2014 Employee Stock Purchasing Plan. Reporting Person acquired 2,459 shares on June 30, 2015 and 541 shares on December 31, 2015. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.